{"nct_id":"NCT02289898","title":"Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma","status":"COMPLETED","status_verified_date":"2020-09","start_date":"2015-04-20","start_date_type":"ACTUAL","primary_completion_date":"2017-05","primary_completion_date_type":"ACTUAL","completion_date":"2017-09","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MREO"]}